baber/WOPTO huggingface dataset:
Patent NZ-512528-A (NZ)
Title: Self-coating composite stabilizing yarn
Inventor: SWERS DAVID N
IPC: D02G3/40
Filed: 1999-12-16
Abstract: A self-coating composite stabilising yarn for outdoor fabrics comprising; a) a polymeric high melt effect constituent having a melt temperature of at least 280°F selected from the group consisting of acrylic, polyesters, high melt polypropylene, and nylon; b) a polymeric low melt binder constituent having a melt temperature no greater than 280°F selected from the group consisting of polyethylene and low melt polypropylene; c) the difference between the low melt and high melt constituents being a difference in melting points of at least 40°F; d) low and high melt constituents being intermingled to form the composite yarn; e) the composite yarn having a denier of 400-4000; f) whereby the yarn becomes self-coating and self-bonding after being subjected to heat.
Patent NZ-523398-A (NZ)
Title: Canted jig saw or saber saw blade
Inventor: GAFFNEY THOMAS M
IPC: B23D61/12
Filed: 2002-12-24
Abstract: A saw blade (12) comprising: a cutting portion having a toothed edge and an opposite edge, the toothed edge defining a cutting plane; and a shank extending from the cutting portion and laterally offset from the opposite edge defining a step (38) thereat, the shank having an end portion including a mounting edge (100), the mounting edge and the step defining a mounting plane, the mounting plane angularly offset from the cutting plane.
Patent NZ-523685-A (NZ)
Title: Improvements in and relating to respiratory apparatus
Inventor: MILLER DONALD MUNRO
IPC: A61M16/04
Filed: 2001-07-13
Abstract: An artificial airway device (10) of a resilient material for use as a combined obturator and airway device without penetration into a larynx comprising a pre-formed flexible saccular chamber (14) and having a semi-rigid hollow stem (14) projecting from a position at or near one end of the chamber at an obtuse angle and capable of being flexed into a curve that deviates up to 90 degrees from the longitudinal axis of the said chamber, the chamber being provided with one or more openings, and dimensioned and arranged so that in use the chamber is adapted to sealingly engage in a patient's pharynx with at least one opening in communication with the patient's laryngeal inlet and the stem extends into or through the patient's mouth for connection to a breathing circuit.
Patent NZ-524293-A (NZ)
Title: Potentiation of biocide activity using a diethanolamide
Inventor: KING VANJA E
IPC: A01N37/20
Filed: 1999-02-24
Abstract: A biocidal composition comprising: a) At least one biocide selected from the group consisting of potassium N-hydroxymethyl-N-methyl thiocarbamate, 2-thiocyanomethylthiobenzothiazole and mixtures thereof; b) At least one diethanolamide of a C12-C22 fatty acid Wherein b) potentiates the biocidal activity of a) to control the growth of at least one microorganism. Theabove biocide composition is useful in the control of microorganisms. (62) Divided out of 506500
Patent NZ-528690-A (NZ)
Title: Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
Inventor: GAGNON LYNE
IPC: A61P17/02
Filed: 2002-04-18
Abstract: Disclosed herein is a composition and method for promoting neutrophil survival and activation such as the treatment of neutropenia arising as an undesirable side effect of chemotherapy and radiation therapy. A composition containing medium-chain fatty acids, such as capri acid or caprylic acid, or salts or triglycerides thereof, or mono- or diglycerides or other analogues thereof or medium-chain triglycerides (MCT) is administered to a human or animal needing treatment in an amount sufficient to reduce or eliminate neutropenia. The composition is administered in an amount effective to treat the disorder. The methods are also useful in the management of bone narrow transplantation and in the treatment of various neutropenic diseases. Particularly disclosed is a the use of a compound of formula (R1-CO-C)nM or a salt thereof for the manufacture of a medicament for the treatment of a condition selected from myelosuppression, wounds, bone marrow transplantation and neutropenia is disclosed, wherein R1 is C7-11 alkyl and M is a metal monocation (n=1) or dication (n=2).
Patent NZ-531367-A (NZ)
Title: Improvements in and relating to reading identification devices
Inventor: BROOM JAMIE DEREK
Filed: 2004-02-24
Abstract: A hand-held Electronic ID (EID) reader for animal tags featuring a flexible antenna portion being substantially flat and including an embedded antenna in communication with a reader portion, this antenna portion being suitable for use in reading a variety of different EID types including ear tags and boluses. Data logging may be carried out within the reader or the reader portion may communicate with an external data logging means by wired or wireless connection.
Patent NZ-535245-A (NZ)
Title: Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgesics
Inventor: ORNSTEIN PAUL LESLIE
IPC: A61K31/4709
Filed: 2003-04-14
Abstract: Disclosed are prodrug forms of (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid of the formula shown wherein R represents C1-C10 alkyl. The prodrugs of the type disclosed are useful for treating pain and in particular for treating migraine.
Patent NZ-536585-A (NZ)
Title: Cheese flavoring systems prepared with bacterocins
Inventor: DIAS BENJAMIN E
IPC: A23L27/20
Filed: 2004-11-16
Abstract: Disclosed herein is a flavouring system for food products obtained by addition of a bacterocin source as part of the fermentation process that accelerates at least part of the fermentation time needed for flavour development in one or more of its flavour components, and comprises a sulfury-cheddar flavour component, a cheesy flavour component and a creamy-buttery flavour component.
Patent NZ-539651-A (NZ)
Title: Compositions and methods for the modification of gene transcription
Inventor: WOOD MARION
IPC: C07K14/415
Filed: 2000-03-09
Abstract: Disclosed is an isolated polynucleotide comprising the nucleic acid sequence SEQ ID NO 2048, or conservative variants thereof, that encodes Myb plant transcription factors. Also disclosed is a DNA construct comprising at least one polynucleotide having the sequence of SEQ ID NO 2048, or conservative variants thereof. Also disclosed is a plant cell , or wood obtained from a transgenic tree, or wood pulp obtained from a transgenic tree, or fruit, seeds or other reproductive material from a transgenic plant, which has been transformed with the above DNA construct.
Patent NZ-545306-A (NZ)
Title: Combinations of a pyrimidine containing NNRTI with RT inhibitors
Inventor: STOFFELS PAUL
IPC: A61K31/52
Filed: 2004-09-03
Abstract: Provided is a combination comprising (i) 4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]-amino]benzonitrile, also named TMC278, or a stereoisomeric form thereof; or a pharmaceutically acceptable salt thereof; and (ii) tenofovir or its prodrug tenofovir disoproxil fumarate, and (iii) emtricitabine. Further provided are combinations of TMC278 with tenofovir and lamivudine, tenofovir and abacavir, lamivudine and emtricitabine, abacavir and emtricitabine as well as lamivuding and abacavir. Also provided is the use of the combinations for the manufacture of a medicament to prevent HIV infection or transmission.
Patent NZ-552999-A (NZ)
Title: Low sidestream smoke cigarette with combustible paper having modified ash characteristics
Inventor: SNAIDR STANISLAV M
IPC: D21H27/00
Filed: 2003-03-14
Abstract: Disclosed is a low sidestream smoke cigarette comprising a conventional tobacco rod and a combustible treatment paper. The treatment paper has a sidestream smoke treatment composition comprising an oxygen storage and donor metal oxide oxidation catalyst and a non-combustible finely divided particulate adjunct for said catalyst.
Patent NZ-554114-A (NZ)
Title: Plants with an increased ratio of oleosin to TAG synthesising enzymes
Inventor: COOKSON RUTH JOCELYN
IPC: C07H21/00
Filed: 2007-04-23
Abstract: Disclosed is a construct which includes: a) at least one promoter; b) a nucleic acid molecule encoding a single oleosin protein; and c) at least one nucleic acid molecule encoding an triacylglycerol biosynthetic enzyme (TAG synthesising enzyme); wherein the promoter(s) are operatively linked to the nucleic acid molecules so as to cause expression of the oleosin and at least one TAG synthesising enzyme. The construct can be used to produce plants with an increased ratio of oleosin to TAG synthesising enzymes. These plants are useful as animal feed.
Patent NZ-555299-A (NZ)
Title: Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Inventor: BELL ROBERT G
IPC: A61K31/567
Filed: 2002-12-04
Abstract: Disclosed is the use of estrogen and progestin in the manufacture of an oral contraceptive, or a medicament for treating PMS or diminishing an estrogen withdrawal symptom, where the medicament is to be administered in a 91-day regime. Further disclosed is the administration of the same in combination with an antidepressant.
Patent NZ-564093-A (NZ)
Title: Method for the treatment of acne using an oral minocycline antibiotic
Inventor: WORTZMAN MITCHELL
IPC: A61K31/65
Filed: 2006-06-19
Abstract: Disclosed is the use of a continuous slow release oral dosage form to treat acne vulgaris wherein the dosage form comprises: an amount of an oral minocycline antibiotic that provides the person, upon administration of said oral dosage form once daily without a loading dose, with 0.7 mg/kg/day to 1.3 mg/kg/day of said oral minocycline antibiotic; and a delivery vehicle, wherein said delivery vehicle releases said oral minocycline antibiotic at a release rate of: (a) about 25% to about 52% within about I hour, about 53% to about 89% within about 2 hours, and at least about 90% within about 4 hours; or (b) about 30% to about 52% within about 1 hour, about 53% to about 84% within about 2 hours, and at least about 85% within about 4 hours. Also disclosed are oral dosage forms for use in the above method.
Patent NZ-570222-A (NZ)
Title: A method and apparatus for arranging articles using vibration and pressure and forming a recess in a surface of the articles
Inventor: BROUGH NEIL FREDERICK
IPC: B65B5/04
Filed: 2009-02-04
Abstract: Disclosed is a method of and apparatus for arranging a plurality of discrete articles in a container. The discrete articles provide a discrete mass of articles. The method includes the steps of vibrating the container to cause movement of the discrete articles in the container; and applying pressure to the articles in the container. The two steps occur substantially at the same time, and the method causes the articles to adopt a configuration providing a recess in a surface of the discrete mass of articles in the container.
Patent NZ-573571-A (NZ)
Title: Treating obesity with telenzepine and an antidepressant selected from sertraline, citalopram, venlafaxine and sibutramine
Inventor: SEED BRIAN
IPC: A61K31/36
Filed: 2007-06-15
Abstract: Disclosed herein is the use of telenzepine and an antidepressant selected from the group consisting of sertraline, citalopram, venlafaxine and sibutramine in the manufacture of a medicament for promoting weight loss or facilitating maintenance of a stable weight. Also disclosed are pharmaceutical compositions comprising a mixture of therapeutically effective amounts of telenzepine and above mentioned antidepressants; and also kits comprising the same.
Patent NZ-573757-A (NZ)
Title: Coated multilayer oral dosage forms of naltrexone hydrochloride
Inventor: MATTHEWS FRANK
IPC: A61K9/50
Filed: 2007-06-19
Abstract: Disclosed is an oral dosage form which comprises a plurality of multi-layer pellets which contain: a) a water-soluble core; b) an antagonist containing layer comprising naltrexone hydrochloride coating the core; c) a sequestering polymer layer coating the antagonist containing layer (such as copolymers of acrylic and methacrylic acid esters with quaternary ammonium groups); and d) an osmotic pressure regulating agent layer which comprises sodium chloride and which forms a coating over said sequestering polymer layer. Further disclosed is an oral dosage form which further comprises an opioid agonist such as morphine or oxycodone.
Patent NZ-576076-A (NZ)
Title: Support for signage and/or lighting with bracket bolted through road barrier and having formed of plate and outstanding platform with gusset(s) for supporting the signage and/or lighting
Inventor: PRATT DAVID MATTHEW
IPC: E01F9/669
Filed: 2009-04-03
Abstract: A signage and/or lighting assembly has a road barrier or linked road barrier members, where a mounting bracket is bolted through the barrier or member to support directly or indirectly signage and/or lighting. The bracket has a mounting plate with openings to allow bolting to and/or through such a barrier or member, a platform outstanding from the mounting plate and at least one gusset supporting the platform from the plate. The platform has openings, slots and/or rebates adapted to support a pole or support of signage and/or lighting.
Patent NZ-577303-A (NZ)
Title: Nucleotides and nucleosides having derivitized bases including a dye and terminating group and uses in DNA sequencing
Inventor: LITOSH VLADISLAV A
IPC: C07H21/04
Filed: 2007-12-05
Abstract: Provided are nucleotides and nucleosides having formulas I-VII that can be used in DNA sequencing and analysis. The nucleotides or nucleosides have an unprotected 3'-OH group and are derivatized at the nucleobase to include a fluorescent dye attached via a linker to a non-cleavable terminating group. The non-cleavable-fluorescent group is designed to terminate DNA synthesis so that DNA oligomers can be sequenced efficiently in a parallel format. Alternatively the nucleotide or nucleoside have an unprotected 3'-OH group and are derivatized at the nucleobase to include a fluorescent dye attached via a linker to a photocleavable terminating group. The photocleavable-fluorescent group is designed to terminate DNA synthesis as well as to be cleaved so that DNA oligomers can be sequenced efficiently in a parallel format.
Patent NZ-582948-A (NZ)
Title: Polymer networks comprising active ingredients, process for their production, and their use
Inventor: TERRENOIRE ALEXANDRE
IPC: A61L9/04
Filed: 2008-07-25
Abstract: Disclosed is a process for producing an actives-comprising polymeric network by mixing polymerizable oligomers and actives and also, optionally, further monomers and/or auxiliaries, followed by thermal or photochemical polymerization of the mixture, wherein the polymerizable mixture comprises the following components: (A) 19.9 to 99.8 percent by weight of at least one oligomer containing mono(meth)acrylate groups and having an average molar mass of 350 to 5000 grams per molecule, selected from the group of epoxy (meth)acrylates, polyester (meth)acrylates, urethane (meth)acrylates or polyether (meth)acrylates, the arithmetic average of the number of (meth)acrylate groups per oligomer molecule being 2.1 to 5; (B) 0 to 49.8 percent by weight of at least one monomer containing olefinic groups and having a molar mass of less than 350 grams per molecule; (C) 0.1 to 8 percent by weight of at least one polymerization initiator which is soluble in the photopolymerizable mixture; (D) 0.1 to 80 percent by weight of at least one active which is dispersible or soluble in the photopolymerizable mixture; and (E) 0 to 20 percent by weight of further auxiliaries and/or additives. Further disclosed is an actives-comprising polymeric network obtainable by said process, and the use of said actives-comprising polymeric network for protecting industrial materials, films, paints and dispersions, crops, and for controlling plant growth.
Patent NZ-587356-A (NZ)
Title: Pesticidal combinations comprising prochloraz, metconazole and optionally metalaxyl or mefenoxam
Inventor: ZEUN RONALD
IPC: A01N37/46
Filed: 2009-02-24
Abstract: Disclosed herein is a method for controlling or preventing pathogenic damage and/or pest damage in a plant propagation material, a plant, part of a plant and/or plant organ that grow at a later point in time, which comprises applying on the plant, part of the plant, plant organ, plant propagation material or a surrounding area thereof a combination comprising (I) prochloraz, (II) metconazole, and optionall (III) metalazyl or mefenoxam, preferable with a mass ratio between any two active ingredients from about 100:1 to 1:100. Also disclosed is the combination comprising (I) prochloraz, (II) metconazole, and optionall (III) metalazyl or mefenoxam.
Patent NZ-594524-A (NZ)
Title: Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function
Inventor: BRADFORD WILLIAMSON ZIEGLER
IPC: A61K31/4709
Filed: 2010-02-26
Abstract: 594524 Disclosed is a composition comprising ?-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine (compound 1) and (1S, 4R, 6S, 14S, 18R)-4-Fluoro-1,3-dihydro-isoindole-2-carboxylic acid 14-tert-butoxycarbonylamino-4-cyclopropanesulfonylaminocarbonyl-2,15-dioxo-3,16-diaza-tricyclo[14.3.0.04,6]nonadec-7-en-18-yl ester (Compound 2). Also disclosed is a method of treating hepatitis C virus infection, liver fibrosis, and impaired liver function in a non-human animal with the composition and the use of the composition in the manufacture of a medicament for the treatment of hepatitis C virus infection, liver fibrosis, and impaired liver function.
Patent NZ-597604-A (NZ)
Title: Power lead testing system and electronic tag
Inventor: MORTON STEPHEN ALLEN
IPC: G01R31/02
Filed: 2010-06-20
Abstract: 597604 Disclosed is a power lead testing system. The system includes a test unit (8) for applying standard voltage and continuity tests to a lead under test (10) and an electronic tag (4) having a countdown timer. The tag (4) communicates with the test unit (8) which resets the timer for a defined period when the lead (10) passes the applied voltage and continuity tests. Also included is a circuit breaker (6) which is triggered when the lead (10) fails either the voltage or continuity test or when the countdown time elapses, thus isolating the lead (10).
Patent NZ-598148-A (NZ)
Title: Methods and apparatuses for managing peak loads for a customer location
Inventor: REE BRADLEY RICHARD
IPC: G01R21/00
Filed: 2012-02-09
Abstract: Disclosed is an apparatus (205) for managing peak loads for a customer location comprised of at least one communications interface (236) and at least one processor (232). The at least one communications interface (236) communicates with a home area network that includes one or more home devices. The at least one communications interface (236) is also in communication with the at least one processor (232). The at least one processor (232) is configured to receive an allocation request from at least a first home device of the one or more home devices. This request is for the first home device to be allocated an amount of power. The processor (232) is configured to then determine an amount of power remaining to allocate out of a total power budget and determine the extent to which the allocation request can be fulfilled based on the remaining power to be allocated. The processor (232) is configured to then send a response to the first home device indicating the extent to which the first home device is permitted to access the requested power allocation. The apparatus (205) may comprise a utility meter.
Patent NZ-600240-A (NZ)
Title: Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
Inventor: COOK JAMES H II
IPC: C07D263/52
Filed: 2009-10-29
Abstract: 600240 The disclosure provides quinuclidine compounds of formula I their sterio isomers, and including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the alpha-7 nicotinic acetylcholine receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders. Compounds of the disclosure include: (R)-N-(6-(1H-imidazol-1-yl)pyrimidin-4-yl)-4H-1’-azaspiro[oxazole-5,3’-bicyclo[2.2.2]5 octan]-2-amine, (R)-N-(3,4’-Bipyridin-2’-yl)-4H-1’-azaspiro[oxazole-5,3’-bicyclo[2.2.2]octan]-2-amine, And (3R)-N-(6-chloro-5-bromopyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5’-4H-1,3-oxazole]-2’-amine
Patent NZ-600868-A (NZ)
Title: An elongate heater for an electrically heated aerosol-generating system
Inventor: GREIM OLIVIER
IPC: A24F40/20
Filed: 2010-12-22
Abstract: Disclosed is a heating element for heating an aerosol-forming substrate in an electric cigarette to allow the controller to fit within a standard sized product. The heating element (121) comprises a first electrically conductive element (105) electrically insulated from a second electrically conductive element (109) by an electrically insulating portion (103). The first and second elements are elongate and are electrically connected to each other by an electrically resistive portion (117, 119). The electrically resistive portion has a higher resistance than the electrically conductive elements, and when in use, at least one electrically conductive element and the electrically resistive portion are arranged such that they are at least partially in contact with the aerosol forming substrate. An electrically heated aerosol-generating system for receiving an aerosol-forming substrate, comprising a heating element is also disclosed.
Patent NZ-602247-A (NZ)
Title: Endoparasiticidal compositions
Inventor: ROLFE PETER
IPC: A61P33/00
Filed: 2011-03-24
Abstract: The disclosure relates to a synergistic composition for controlling endoparasites in and on animals, which comprises a combination of (i) N-((1S)-1-cyano-2-(5-cyano-2-trifluoromethylphenoxy)-1-methylethyl)-4-trifluoromethylsuIfanylbenzamide (monepantel) represented by formula (I) and (ii) abamectin. The compositions are useful in the control of endoparasites, in particular helminths, in and on warm-blooded animals.
Patent NZ-602950-A (NZ)
Title: A method for synthesis of radiolabelled guanidine derivatives
Inventor: BUGGE STEFFEN
IPC: A61K51/00
Filed: 2011-05-13
Abstract: Disclosed is a method to obtain a positron emission tomography (PET) tracer of Formula (I), particularly 3-(2-chloro-5-((2-[18-F]-fluoroethyl)thio)phenyl)-1-methyl-1-(3-(methylthio)phenyl)guanidine, wherein: X1 is an X group selected from alkyl or halo; Y1 is a Y group selected from hydrogen or alkyl; Z1 is a Z group which is alkyl; and, Q is [11C]C1-4alkyl- or [18F]-C1-4fluoroalkyl-; wherein said method comprises: (a) providing a compound of Formula (II), wherein: X11 and X12 are the same and are both an X group as defined for X1; Y11 and Y12 are the same and are both a Y group as defined for Y1; and, Z11 and Z12 are the same and are both a Z group as defined for Z1; (b) reducing said compound of Formula (II) with a reducing agent (such as sodium borohydride, zinc in hydrochloric acid, zinc in acetic acid, magnesium in hydrochloric acid, sodium hydrogentelluride (NaTeH) in ethanol, lithium aluminium hydride in tetrahydrofuran, indium in ammonium chloride, and sodium hydride) to obtain a compound of Formula (III), wherein: X21 is an X group as defined for X1; Y21 is a Y group as defined for Y1; and Z21 is a Z group as defined for Z1; (c) reacting the compound of Formula III as obtained in step (b), with either [11C]C1-4 alkyl-LG1 or [18F]-C1-4fluoroalkyl-LG2, wherein LG1 and LG2 are independently halo, or the group -O-SO2-R1, wherein R1 represents an optionally-substituted aryl, an optionally-substituted alkyl, or fluoroalkyl, wherein said reacting is carried out in a suitable solvent. Further disclosed is a cassette for automatically carrying out the method as defined above, wherein said cassette comprises: (i) a vessel containing the compound of Formula (II); (ii) means for reacting said compound of Formula (II) with a reducing agent to form a compound of Formula (III); and, (iii) means for reacting said compound of Formula (III) with either [11C]C1-4alkyl-LG1 or [18F]-C1-4 fluoroalkyl-LG2 to obtain a PET tracer of Formula (I).